334
Views
10
CrossRef citations to date
0
Altmetric
Non-themed Articles

In silico and in vitro methods to optimize the performance of experimental gastroretentive floating mini-tablets

, , , , &
Pages 808-817 | Received 20 Jan 2015, Accepted 24 Jul 2015, Published online: 25 Aug 2015

References

  • Prinderre P, Sauzet C, Fuxen C. Advances in gastro retentive drug-delivery systems. Expert Opin Drug Deliv 2011;8:1189–203
  • Pawar VK, Kansal S, Garg G, et al. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems. Drug Deliv 2011;18:97–110
  • Talukder R, Fassihi R. Gastroretentive delivery systems: a mini review. Drug Dev Ind Pharm 2004;30:1019–28
  • Nayak AK, Malakar J, Sen KK. Gastroretentive drug delivery technologies: current approaches and future potential. J Pharm Educ Res 2010;1:1–12
  • Pawar VK, Kansal S, Asthana S, Chourasia MK. Industrial perspective of gastroretentive drug delivery systems: physicochemical, biopharmaceutical, technological and regulatory consideration. Expert Opin Drug Deliv 2012;9:551–65
  • Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery systems. Expert Opin Drug Deliv 2006;3:217–33
  • Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release 2000;63:235–59
  • Kawashima Y, Takeuchi H, Yamamoto H. A gastrointestinal retentive microparticulate system to improve oral drug delivery. In: Wise DL, ed. Handbook of pharmaceutical controlled release technology. New York: CRC Press; 2000:505–25
  • Whitehead L, Fell JT, Collett JH, et al. Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J Control Release 1998;55:3–12
  • Soppimath KS, Kulkarni AR, Rudzinski WE, Aminabhavi TM. Microspheres as floating drug-delivery systems to increase gastric retention of drugs. Drug Metab Rev 2001;33:149–60
  • Prajapati VD, Jani GK, Khutliwala TA, Zala BS. Raft forming system—an upcoming approach of gastroretentive drug delivery system. J Control Release 2013;168:151–65
  • Pillay V, Choonara Y, Murphy C, Moonisami S. Multi-unit gastroretentive pharmaceutical dosage form comprising microparticles. US8778396 B2, 2014. Available from: http://www.google.com/patents/US8778396 [last accessed 4 Jun 2015]
  • Dennis A, Timmins P, Lee K. Buoyant controlled release powder formulation. US 5169638 A, 1992
  • Yuasa H, Takashima Y, Kanaya Y. Studies on the development of intragastric floating and sustained release preparation. I. Application of calcium silicate as a floating carrier. Chem Pharm Bull (Tokyo) 1996;44:1361–6
  • Inouye K, Machida Y, Sannan T, Nagai T. Buoyant sustained release granules based on chitosan. Drug Des Deliv 1989;4:55–67
  • Kawashima Y, Niwa T, Takeuchi H, et al. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J Control Release 1991;16:279–89
  • Ichikawa M, Kato T, Kawahara M, et al. A new multiple-unit oral floating dosage system. II: in vivo evaluation of floating and sustained-release characteristics with p-aminobenzoic acid and isosorbide dinitrate as model drugs. J Pharm Sci 1991;80:1153–6
  • Rouge N, Cole ET, Doelker E, Buri P. Buoyancy and drug release patterns of floating minitablets containing piretanide and atenolol as model drugs. Pharm Dev Technol 1998;3:73–84
  • Meka L, Kesavan B, Kalamata VN, et al. Design and evaluation of polymeric coated minitablets as multiple unit gastroretentive floating drug delivery systems for furosemide. J Pharm Sci 2008;98:2122–32
  • Imran M, Ranjha NM, Ayoub RK. Controlled-release low density effervescent floating matrix tablets of risperidone: development, optimization, in vitro-in vivo evaluation in healthy human volunteers and determination of dissolution equivalency. Iran J Pharm Sci 2013;9:31–48
  • Venkata Srikanth M, Songa AS, Nali SR, et al. Thermal sintering: a novel technique used in the design, optimization and biopharmaceutical evaluation of propranolol HCl gastric floating tablets. Drug Dev Ind Pharm 2013;40:33–45
  • Timmermans J, Moës AJ. How well do floating dosage forms float? Int J Pharm 1990;62:207–16
  • Eisenächer F, Garbacz G, Mäder K. Physiological relevant in vitro evaluation of polymer coats for gastroretentive floating tablets. Eur J Pharm Biopharm 2014;88:778–86
  • Timmermans J, Moes AJ. Apparatus and method for resultant-weight measuring system. US5076107 A, 1991. Available from: http://www.google.com/patents/US5076107 [last accessed 22 Sep 2014]
  • Parikh DC, Amin AF. In vitro and in vivo techniques to assess the performance of gastro-retentive drug delivery systems: a review. Expert Opin Drug Deliv 2008;5:951–65
  • Sauzet C, Claeys-Bruno M, Nicolas M, et al. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation. Int J Pharm 2009;378:23–9
  • Eberle VA, Schoelkopf J, Gane PAC, et al. Floating gastroretentive drug delivery systems: comparison of experimental and simulated dissolution profiles and floatation behavior. Eur J Pharm Sci 2014;58:34–43
  • Bodea M, Tomuta I, Sorin L. Identification of critical formulation variables for obtaining metoprolol tartrate mini-tablets. Farmacia 2010;58:719–27
  • Aleksovski A, Dreu R, Gašperlin M, Planinšek O. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups. Expert Opin Drug Deliv 2015;12:65–84
  • Stirnimann T, Atria S, Schoelkopf J, et al. Compaction of functionalized calcium carbonate, a porous and crystalline microparticulate material with a lamellar surface. Int J Pharm 2014;466:266–75
  • Puchkov M, Tschirky D, Leuenberger H. 3-D cellular automata in computer-aided design of pharmaceutical formulations: mathematical concept and F-CAD software. In: Aguilar JE, ed. Formulation tools for pharmaceutical development. 1st edn. Cambridge, UK: Woodhead Publishing Limited; 2013:155–201
  • Pitt KG, Heasley MG. Determination of the tensile strength of elongated tablets. Powder Technol 2013;238:169–75
  • Kari J. Theory of cellular automata: a survey. Theor Comput Sci 2005;334:3–33
  • Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), US. Guidance for industry: dissolution testing of immediate-release solid oral dosage forms. 1997. Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070237.pdf [last accessed 23 Dec 2014]
  • Pearson K. Note on regression and inheritance in the case of two parents. Proc Roy Soc Lond 1895;58:240–2
  • Kong F, Singh RP. A human gastric simulator (HGS) to study food digestion in human stomach. J Food Sci 2010;75:E627–35
  • Watanabe S, Kayano M, Ishino Y, Miyao K. Solid therapeutic preparation remaining in stomach. US3976764 A, 1976. Available from: http://www.google.com/patents/US3976764 [last accessed 23 Dec 2014]
  • Narendra C, Srinath MS, Babu G. Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention. AAPS PharmSciTech 2006;7:E23–9
  • Chaturvedi S, Kumari P, Singh S, Agrawal Vipin K. Approaches to increase the gastric residence time: floating drug delivery systems – a review. 2013;6:1–9
  • Amit JK, Rammulrajsinh R, Sonali D, et al. Hydrodynamically balanced systems (HBS): innovative approach of gastroretention: a review. Int J Pharm Tech Res 2011;3:1495–508
  • Goole J, Vanderbist F, Amighi K. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int J Pharm 2007;334:35–41
  • Goole J, Deleuze P, Vanderbist F, Amighi K. New levodopa sustained-release floating minitablets coated with insoluble acrylic polymer. Eur J Pharm Biopharm 2008;68:310–8
  • Narang N. An updated review on: floating drug delivery system (FDDS). Int J Appl Pharm 2011;3:1–7
  • Preisig D, Haid D, Varum FJO, et al. Drug loading into porous calcium carbonate microparticles by solvent evaporation. Eur J Pharm Biopharm 2014;87:548–58

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.